Apotex, on behalf of Hospira, announced that it is recalling an additional 21 lots of Piperacillin/Tazobactam for Injection 40.5g due to the possible precipitation/crystallization in the IV bag or IV line after reconstitution. Apotex issued an initial recall of Piperacillin/Tazobactam for Injection on April 30, 2013.
The affected lots are packaged in 300mL glass vials for reconstitution and have an NDC #60505-0773-00 with expiration dates ranging from 8/2013–4/2014. Apotex will notify its direct account customers by sending the recall notification letter and arranging for product return of all recalled product. The full list of affected products can be viewed here.
Piperacillin/Tazobactam is a broad-spectrum penicillin + β-lactamase inhibitor combination indicated for the treatment of susceptible skin and skin structure infections, moderately severe community-acquired pneumonia, moderate to severe nosocomial pneumonia, postpartum endometritis, pelvic inflammatory disease, complicated appendicitis, and peritonitis.
For more information call (877) 674-2078 or visit the Apotex website.